Target intelligence / Profile preview

Islet cell autoantigen 1, 69kDa pseudogene (null)

Target
null
Molecular classification
Pseudogene, Other
01

Overview

The "Islet cell autoantigen 1, 69kDa pseudogene" designates a *pseudogene* (nonfunctional genomic DNA sequence resembling a gene) related to *ICA1*, which encodes the protein ICA69, a known islet autoantigen in type 1 diabetes. The pseudogene itself does not produce a functional protein and therefore is not a therapeutic target, nor does it possess direct biological function or disease association. It lacks the properties of typical drug targets like receptors, enzymes, or transporters[1]. In clinical and experimental literature, *ICA69* is discussed for its role in autoimmunity, particularly type 1 diabetes[3][7], but *the pseudogene* (as identified by ENSG00000260395) is not functionally involved. If your interest is in the protein with autoimmune relevance, search for *Islet cell autoantigen 1, 69kDa* (ICA1), not the pseudogene[1][3][7]. Notes on correctness and interpretation: - *Is this a therapeutic target?* No. The pseudogene has no known function or role as a drug target. - *Is something wrong with this target?* Yes. This is a pseudogene, not an active gene or target protein. If drug discovery or functional studies are intended, the proper target is ICA1 (Islet cell autoantigen 1, 69kDa), not its pseudogene. - *Aliases:* The names found in public databases may include LOC100420536, which strictly refers to the pseudogene. - *If searching for target biology, functional studies, or druggability, ICD69/ICA1 is the correct functional gene/protein.*

Other names
ICA1 pseudogeneICA69 pseudogeneLOC100420536
02

Mechanism of action

null

Beyond the preview

Go deeper on Islet cell autoantigen 1, 69kDa pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Islet cell autoantigen 1, 69kDa pseudogene (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call